Immune protection application of staphylococcus aureus EsxA protein
A staphylococcus, immune protection technology, applied in the field of immune vaccines, can solve the problem of weakening pathogenicity and achieve remarkable results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0013] 1. Preparation of EsxA vaccine
[0014] The EsxA vaccines were prepared respectively at a mass ratio of EsxA protein / aluminum hydroxide adjuvant of 1:2.5.
[0015] 2. Immunization of BALB / c mice
[0016] Immunized mice:
[0017] EsxA vaccine group: On days 1, 7, and 21, 200 μL of vaccine containing 200 μg / mL EsxA and 500 μg / mL aluminum hydroxide adjuvant was subcutaneously injected into the back of each four-week-old mouse, and blood was collected intravenously on day 28 to detect anti- EsxA antibody production.
[0018] Control group: On days 1, 7, and 21, each mouse was subcutaneously injected with 200 μL of vaccine containing 500 μg / mL aluminum hydroxide adjuvant on the back, and blood was collected intravenously on day 28.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 